Using Early Time-Restricted Feeding and Timed Light Therapy to Improve Glycemic Control in Adults with Type 2 Diabetes
Abstract
In this clinical trial, we will test whether two circadian-based therapies--a form of meal timing called early time-restricted eating (eTRE) and timed light therapy--can improve blood sugar control in adults with type 2 diabetes. Approximately 344 adults with type 2 diabetes will be randomized to the following 2 x 2 study design: (1) control group, (2) eTRF, (3) timed light therapy, and (4) eTRF and timed light therapy. Participants will follow their assigned lifestyle intervention for 16 weeks and be followed for a total of one year. In addition, we will determine whether the two circadian therapies can improve circadian rhythms, sleep quality, weight loss, cardiovascular health, quality of life, andpsychological health. We will also determine which patients benefit the most from these therapies. At the start of year 2, our facilities were still shut down due to the COVID-19 pandemic. Thereafter, they re-opened, and we resumed research. We finished setting up the clinical trial and completed the renovation and expansion of inpatient testing rooms in the hospital. We began recruiting and enrolling participants. Our first participant has completed the 16-week intervention. The delivery of the intervention is going well, and retention is very high. We are currently preparing larger advertising campaigns to enroll more people.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2021
- Accession Number
- AD1156708
Entities
People
- Courtney M. Peterson
- Kimberly Armstead
- Rachel Benz
Organizations
- University of Alabama